Keywords: fda, begins, safety, review, laba, asthma, drugs

US FDA begins safety review of LABA asthma drugs

Article | 10 March 2008

Print This

The US Food and Drug Administration has requested information from makers of long acting beta-2 agonist (LABA) drugs, which are ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in